Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04238806
Other study ID # 2013.3/13
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2013
Est. completion date September 30, 2014

Study information

Verified date January 2020
Source Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During coronary artery bypass grafting (CABG) operations with cardiopulmonary bypass (CPB), the use of desflurane continuously or intermittently may have effects on serum brain natriuretic peptide (BNP) levels. The aim is to investigate the association between desflurane, serum BNP values, and clinical outcomes during CABG operations. In a prospective, randomized, double-blinded study, desflurane inhalational anesthesia was administered either continuously or intermittently (Group 1; n=60 versus Group 2; n=62). The preoperative and postoperative BNP levels at 24, 48 and 72 hours after surgery were collected. Outcomes were recorded.


Description:

Background: During coronary artery bypass grafting (CABG) operations with cardiopulmonary bypass (CPB), the use of desflurane continuously or intermittently may have effects on serum brain natriuretic peptide (BNP) levels.

Aim of the study: The aim is to investigate the association between desflurane, serum BNP values, and clinical outcomes during CABG operations.

Material and methods: In a prospective, randomized, double-blinded study, desflurane inhalational anesthesia was administered either continuously or intermittently (Group 1; n=60 versus Group 2; n=62). The preoperative and postoperative BNP levels at 24, 48 and 72 hours after surgery were collected. Outcomes were recorded. Randomization into two groups was performed using sealed envelopes. The sequentially numbered assignments of participants were concealed in these envelopes during the study. The patients enrolled in the study receive an allocation to a group after anesthesia induction by health care personnel after the opening of the envelope. The observers were blinded to the anesthetic protocol. Caregivers were not blinded, but they did not participate in data collection or data interpretation. Therefore, the study protocol is considered double-blinded, masked to observers. Inclusion criteria include; 18 to 75 years of age, body mass index of 25 to 31, ejection fraction≥50%. Exclusion criteria include; repeat cardiac surgery, emergent surgery, preoperative coagulation disorder, preoperative congestive heart failure, ejection fraction <49%, preoperative renal dysfunction (serum creatinine>1.3 mg/dL), dialysis, preoperative hepatic dysfunction (serum aspartate/alanine amino transferase>40 U/L), preoperative electrolyte imbalance, history of pancreatitis or current corticosteroid treatment.The primary endpoint was to determine preoperative and postoperative BNP values 24, 48 and 72 hours after surgery. The secondary endpoint was the relation between BNP values and clinical outcomes such as; 1-Aortic cross-clamp time, 2-Cardiopulmonary bypass time, 3-The use of inotropic support, 4-Intra-aortic balloon pump, 5-Duration of mechanical ventilation (>48 hours), 6-Development of pneumonia, 7-Perioperative myocardial infarction, 8-Cerebrovascular event (stroke or transient ischemic attack), seizure, 9-Atrial fibrillation and other rhythm disturbances, 10-Need for renal replacement therapy (RRT), 11-Reoperation secondary to bleeding, 12-Intensive care unit stay (>3 days), 13-Hospital stay and, 14-Thirty-day mortality.

Statistical analysis. The sample size was calculated according to the comparison of serum BNP values in a previous study and a sample size of 58 patients per group would be required with 80% power and the conventional 2-sided type 1 error of 5%. A multiple logistic regression analysis was performed to assess the predictive factors for weaning failure from mechanical ventilation, and the significance level was set at a p-value of less than 0.10 in the univariate model. To determine the best cut-off for preoperative BNP value to predict the development of prolonged mechanical ventilation, we calculated the area under the receiver operating characteristic curve.


Recruitment information / eligibility

Status Completed
Enrollment 151
Est. completion date September 30, 2014
Est. primary completion date August 31, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Eighteen to seventy-five years of age,

- Body mass index values between twenty-five and thirty-one,

- Ejection fraction greater than or equal to 50%.

Exclusion Criteria:

- Repeat cardiac surgery,

- Emergent surgery,

- Preoperative coagulation disorder,

- Preoperative congestive heart failure,

- Ejection fraction less than 49%,

- Preoperative renal dysfunction (serum creatinine value of greater than 1.3 mg/dL),

- Dialysis,

- Preoperative hepatic dysfunction (serum aspartate/alanine amino transferase values of greater than 40 U/L),

- Preoperative electrolyte imbalance,

- History of pancreatitis,

- Current corticosteroid treatment.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Desflurane Inhalational agent
Desflurane inhalational agent administration during the whole cardiac surgical operation with cardiopulmonary bypass versus administration of desflurane inhalational agent before and after cardiopulmonary bypass during the whole period of cardiac surgical operation.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital Trakya University Faculty of Medicine Hospital

References & Publications (11)

Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Alozairi O, Brittenden J, Hillis GS. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth. 2007 Aug;99(2):170-6. — View Citation

Cuthbertson BH, Croal BL, Rae D, Gibson PH, McNeilly JD, Jeffrey RR, Smith WC, Prescott GJ, Buchan KG, El-Shafei H, Gibson GA, Hillis GS. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. — View Citation

De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, Rodrigus IE, Van der Linden PJ. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesth — View Citation

Fox AA, Nascimben L, Body SC, Collard CD, Mitani AA, Liu KY, Muehlschlegel JD, Shernan SK, Marcantonio ER. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass — View Citation

Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol — View Citation

Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh HM, Devereaux PJ. Is a pre-operative brain natriuretic peptide or N-terminal pro — View Citation

Litton E, Ho KM. The use of pre-operative brain natriuretic peptides as a predictor of adverse outcomes after cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2012 Mar;41(3):525-34. doi: 10.1093/ejcts/ezr007. Epub 2011 Oct — View Citation

Lurati Buse GA, Koller MT, Burkhart C, Seeberger MD, Filipovic M. The predictive value of preoperative natriuretic peptide concentrations in adults undergoing surgery: a systematic review and meta-analysis. Anesth Analg. 2011 May;112(5):1019-33. doi: 10.1 — View Citation

Murad Junior JA, Nakazone MA, Machado Mde N, Godoy MF. Predictors of mortality in cardiac surgery: brain natriuretic peptide type B. Rev Bras Cir Cardiovasc. 2015 Mar-Apr;30(2):182-7. doi: 10.5935/1678-9741.20150008. — View Citation

Uhlig C, Bluth T, Schwarz K, Deckert S, Heinrich L, De Hert S, Landoni G, Serpa Neto A, Schultz MJ, Pelosi P, Schmitt J, Gama de Abreu M. Effects of Volatile Anesthetics on Mortality and Postoperative Pulmonary and Other Complications in Patients Undergoi — View Citation

Yun KH, Jeong MH, Oh SK, Choi JH, Rhee SJ, Park EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW. Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. Circ J. 2008 Feb;72(2):195-9. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Serum BNP values before the cardiac surgery Serum BNP values were collected from a blood sample of each patient one day before cardiac surgery One day before cardiac surgery.
Primary Serum BNP values after the cardiac surgery at 24 hours Serum BNP values were collected from a blood sample of each patient after cardiac surgery After operation at 24 hours after cardiac surgery.
Primary Serum BNP values after the cardiac surgery at 48 hours Serum BNP values were collected from a blood sample of each patient after cardiac surgery After operation at 48 hours after cardiac surgery.
Primary Serum BNP values after the cardiac surgery at 72 hours Serum BNP values were collected from a blood sample of each patient after cardiac surgery After operation at 72 hours after cardiac surgery.
Primary Serum BNP values before and after the cardiac surgery The collected serum BNP values were compared with each other by repeated measure analysis After collection of the data and during statistical analysis
Secondary Outcome aortic cross-clamp time A relation between serum BNP values and aortic cross-clamp time During operative time period of cardiac surgery
Secondary Outcome cardiopulmonary bypass time A relation between serum BNP values and cardiopulmonary bypass time During operative time period of cardiac surgery
Secondary Outcome use of inotropic support A relation between serum BNP values and use of inotropic support During operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome use of Intra-aortic balloon pump A relation between serum BNP values and use of Intra-aortic balloon pump During operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome duration of mechanical ventilation (>48 hours) A relation between serum BNP values and duration of mechanical ventilation (>48 hours) After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome development of pneumonia A relation between serum BNP values and development of pneumonia After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome parameters A relation between serum BNP values and perioperative myocardial infarction During operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome cerebrovascular event or seizure A relation between serum BNP values and cerebrovascular event (stroke or transient ischemic attack) or seizure After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome atrial rhythm disturbances A relation between serum BNP values and atrial fibrillation and other atrial rhythm disturbances After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome ventricular rhythm disturbances A relation between serum BNP values and ventricular rhythm disturbances After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome renal replacement therapy A relation between serum BNP values and need for renal replacement therapy (RRT) After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome reoperation A relation between serum BNP values and reoperation secondary to bleeding After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome intensive care unit stay A relation between serum BNP values and intensive care unit stay (>3 days) After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome hospital stay A relation between serum BNP values and intensive care unit stay (>3 days) After operative time period of cardiac surgery and during intensive care unit stay
Secondary Outcome thirty-day mortality A relation between serum BNP values and thirty-day mortality After operative time period of cardiac surgery and during intensive care unit stay
See also
  Status Clinical Trial Phase
Recruiting NCT05054179 - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain Phase 2/Phase 3
Completed NCT04051021 - Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients N/A
Recruiting NCT04604886 - The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients N/A
Recruiting NCT04075981 - Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) Phase 3
Completed NCT04062396 - Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction N/A
Recruiting NCT04709705 - DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS) Phase 2/Phase 3
Not yet recruiting NCT05563662 - SURgical Registry of ENDocarditis EuRope
Withdrawn NCT03289104 - Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX N/A
Completed NCT04199039 - Effects of Endotracheal Tube Fixation Methods on Hemodynamic Parameters During Endotracheal Suction N/A
Completed NCT03563196 - Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
Completed NCT02964026 - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients N/A
Completed NCT02471001 - The Levels of Anaesthetics in Heart Muscle During Heart Surgery N/A
Completed NCT02325726 - RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery. N/A
Completed NCT01246947 - Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation N/A
Completed NCT01151254 - Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation N/A
Completed NCT00821262 - Sevoflurane in Cardiac Surgery Phase 4
Completed NCT00996099 - Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients N/A
Completed NCT00617955 - Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates N/A
Completed NCT00337805 - Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery Phase 2/Phase 3
Completed NCT00336466 - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) Phase 2